Literature DB >> 7944642

Interleukin 1 beta, hand and foot bone mineral content and the development of joint erosions in rheumatoid arthritis.

J North1, R D Situnayake, M Tikly, A Cremona, J Nicoll, D S Kumararatne, G Nuki.   

Abstract

OBJECTIVE: To assess the relationship between plasma levels of the cytokine interleukin-1 beta (IL-1 beta) and the progression of rheumatoid arthritis (RA).
METHODS: Two subgroups of patients, one with persistently raised ESR (>/= 50 mm/hour, n = 16, group A) and one with persistently low ESR (</= 28 mm/hour), n = 18, group I) were chosen to represent stable extremes of inflammatory activity from a prospective study of 106 patients with active RA studied over one year in a single centre. The change from baseline in hand, foot and calcaneal bone mineral content measured by single photon absorptiometry and radiographic score of joint damage was measured over 12 months, together with plasma IL-1 beta and erythrocyte sedimentation rate.
RESULTS: Significant progression of joint damage occurred in both subgroups over one year (p < 0.0001, paired t test) though progression was significantly less in the subgroup with low ESR (p < 0.05, ANOVA). Hand and foot bone mineral content decreased by almost 10% in the subgroup with raised ESR (p < 0.005, paired t test). Stepwise linear regression analysis revealed significant independent relationships between radiographic progression over one year and plasma IL-1 beta and ESR (multiple R 0.674, F = 11.64, p < 0.0002). No such relationships were observed for changes in bone mineral content parameters.
CONCLUSIONS: Plasma IL-1 beta levels correlate weakly with progression of joint damage though not with loss of peripheral bone density in RA. A significant reduction in peripheral bone mineral content occurs over one year in patients with active RA with persistently raised ESR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944642      PMCID: PMC1005397          DOI: 10.1136/ard.53.8.543

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  1 in total

1.  Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

Authors:  J A Eastgate; J A Symons; N C Wood; F M Grinlinton; F S di Giovine; G W Duff
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

  1 in total
  5 in total

1.  Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage.

Authors:  J K de Vries-Bouwstra; Y P M Goekoop-Ruiterman; J Wesoly; H J Hulsmans; A J M de Craen; F C Breedveld; B A C Dijkmans; C F Allaart; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

2.  Detection of TNF alpha and Fas ligand mRNA within synovial mononuclear cells by fluorescence in-cell labeling PCR (FICL-PCR).

Authors:  M Okubo; M P Brown; K Chiba; R Kasukawa; T Nishimaki
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

Review 3.  Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis.

Authors:  R M Nakamura
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

4.  Decreased plasma gonadotropin and testosterone levels in arthritic rats: are corticosteroids involved?

Authors:  C Rivier
Journal:  Endocrine       Date:  1995-05       Impact factor: 3.633

5.  Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis.

Authors:  Matthew R Evans; Agustín Escalante; Daniel F Battafarano; Gregory L Freeman; Daniel H O'Leary; Inmaculada del Rincón
Journal:  Arthritis Rheum       Date:  2011-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.